JupiteX Get the app
Health & Medicine18 Nov 2026 · about 7 min

WHO warns progress on antimicrobial resistance falls short of 2030 targets

The brief

Antimicrobial resistance, or AMR, happens when bacteria and other microorganisms evolve until medicines designed to treat them no longer work. It matters because drug-resistant infections threaten lives and could undermine decades of medical advances. The WHO’s warning is that having a plan on paper is not enough to slow this threat. In a survey of 183 countries, 173 reported having a national AMR plan, up from 79 in 2017. But only 42 said their plans were both funded and implemented. The difference shows how often a government commitment has not yet become practical action. Plans need money and follow-through to support measures such as infection prevention and resistance testing. The WHO, UNEP, the World Organisation for Animal Health and FAO conducted the survey. It found progress in plans and surveillance, but important gaps remain. For example, only 69 countries had implemented infection-prevention programmes nationwide, far below the 2030 target of 90 percent. The WHO warns that the world is falling behind on efforts to contain resistance.

01

What did the WHO say countries have achieved—and what is still missing—in their efforts to tackle antimicrobial resistance?

Antimicrobial resistance, or AMR, happens when bacteria and other microorganisms evolve until medicines designed to treat them no longer work. It matters because drug-resistant infections threaten lives and could undermine decades of medical advances. The WHO’s warning is that having a plan on paper is not enough to slow this threat.

In a survey of 183 countries, 173 reported having a national AMR plan, up from 79 in 2017. But only 42 said their plans were both funded and implemented. The difference shows how often a government commitment has not yet become practical action. Plans need money and follow-through to support measures such as infection prevention and resistance testing.

The WHO, UNEP, the World Organisation for Animal Health and FAO conducted the survey. It found progress in plans and surveillance, but important gaps remain. For example, only 69 countries had implemented infection-prevention programmes nationwide, far below the 2030 target of 90 percent. The WHO warns that the world is falling behind on efforts to contain resistance.

02

Of the 183 countries surveyed, how many had a national plan, and how many had funded and implemented one?

Antimicrobial resistance is a growing threat because bacteria and other microorganisms can evolve until medicines no longer treat them effectively. Countries use national action plans to organize efforts against this problem. But a plan only helps when governments can fund and carry out the actions it sets out.

Of the 183 countries surveyed by the WHO and partner agencies, 173 reported having a national AMR plan. That is up from 79 countries in 2017. Yet just 42 countries said their plans were both funded and implemented. In other words, most countries reported having plans, but far fewer reported having the resources and action needed to put them into effect.

The figures show progress in planning, alongside a substantial implementation gap. The WHO says the world is falling behind on efforts to contain drug-resistant infections. Countries agreed on 2030 targets in 2024, and the survey indicates that commitments still need to be matched with funding and concrete measures to tackle resistance.

03

What is antimicrobial resistance, and what does it mean when a bacterium is resistant to an antibiotic?

Antimicrobial resistance, or AMR, is when bacteria and other microorganisms evolve and no longer respond to medicines designed to treat them. In this question, a resistant bacterium is one that does not respond to the antibiotic intended to treat it. The drug may no longer control the infection as expected, making treatment more difficult.

The WHO says resistance is accelerated by misuse and overuse of antibiotics and other drugs. For example, if antibiotics are used too often, they can contribute to the evolution of bacteria that no longer respond to those medicines. This is why the problem is not limited to one patient or one infection: resistant microbes threaten the effectiveness of medicines used to treat infections more broadly.

The WHO reports that one in six laboratory-confirmed bacterial infections is resistant to antibiotics. The agency warns that resistant infections could contribute to more than 39 million deaths worldwide over the next 25 years if current trends persist. The article also notes that development of new antibiotics is failing to keep pace with resistance.

04

How many countries have implemented infection-prevention programmes nationwide, and how does that compare with the 2030 target?

Infection prevention and control can reduce the need for antibiotics, making it an important part of efforts to tackle antimicrobial resistance. When infections are prevented, there are fewer occasions when medicines are needed. The WHO’s 2026 survey highlights that many countries still have not put prevention programmes into practice nationwide.

The number of countries with national infection-prevention programmes and guidelines rose to 128, from 90 in 2018. But only 69 countries, or 38 percent, had implemented these programmes nationwide. That distinction matters: a country may have a programme and guidance without having it operating throughout the country. The 69 countries represent less than half of the 128 with programmes and guidelines.

Countries have set a 2030 target of 90 percent for nationwide implementation. The current 38 percent is well short of that goal. The survey’s findings point to a major gap between establishing national plans and delivering prevention across the country. Because prevention is one of the most effective ways to reduce antibiotic need, closing that gap is important to containing resistance.

05

What can happen to routine medical procedures when antibiotics no longer work, and how many deaths could drug-resistant infections contribute to if trends continue?

Antibiotics help treat bacterial infections, so resistance can make infections harder to treat. That threat can also affect medical procedures that people now take for granted. Jean Pierre Nyemazi, acting director of the WHO’s AMR department, warned that such procedures become far riskier when antibiotics and antimicrobials no longer work.

The problem is growing as bacteria and other microorganisms evolve and stop responding to medicines designed to treat them. The WHO says misuse and overuse of antibiotics and other drugs accelerate this process. It also reports that one in six laboratory-confirmed bacterial infections is resistant to antibiotics. These figures show that resistance is already affecting infections, not only posing a future risk.

The WHO warns that drug-resistant infections could contribute to more than 39 million deaths worldwide over the next 25 years if current trends persist. It also says development of new antibiotics is failing to keep pace with resistance. Countries agreed to 2030 targets in 2024, but the survey found that implementation and prevention still fall short.

06

Why is it useful for countries to track both antibiotic use and resistance?

Tracking antibiotic use and resistance together helps countries understand how the use of these medicines drives resistance. The WHO says this combined picture can help governments develop more effective strategies to contain resistance. Looking at only one set of information can leave decision-makers without the relationship the WHO says is essential to understanding the problem.

Surveillance has expanded: 113 countries now monitor antibiotic use, and 109 track resistance. In 2017, the corresponding totals were 65 and 39. But having both kinds of monitoring does not necessarily mean that the information is combined. Only 21 countries reported integrating data on antibiotic use and resistance.

That limited integration is a remaining gap despite the growth in surveillance systems. Linking the two sets of data can help governments see how medicine use and resistance move together, then develop more effective ways to contain resistance. The WHO’s survey also found gaps in funding, infection prevention and testing, so stronger use of surveillance data is one part of a broader response needed to meet 2030 targets.

07

How can overusing antibiotics help resistant microbes survive and spread?

Antimicrobial resistance occurs when bacteria and other microorganisms evolve and no longer respond to medicines designed to treat them. The article says misuse and overuse of antibiotics and other drugs accelerate this process. That matters because resistant infections threaten lives and can make medicines less able to treat the infections they were intended for.

In general, overuse creates more opportunities for resistant microbes to survive and multiply while susceptible microbes are affected by treatment. This is a well-established explanation of how antibiotic pressure can favor resistance; the article itself identifies misuse and overuse as accelerators but does not detail this mechanism. Resistant microbes can then contribute to infections that are harder to treat.

The WHO reports that one in six laboratory-confirmed bacterial infections is resistant to antibiotics. It warns that resistant infections could contribute to more than 39 million deaths over the next 25 years if trends continue. The agency also says new antibiotic development is failing to keep pace, making prevention and careful action especially important.

This brief was written by AI from the original reporting and checked by other models. Names, figures and quotes come from the source; read it for full context.

Read more in the JupiteX app

Pulse is free. New stories every 4 hours, each one broken into the questions that explain it.

Or read more news on the web